Showing results (41-50 of 80) with videos related to
Sort By:
Pageof 8
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 30, 2015
Association of p16 gene methylation with prostate cancer risk: a meta-analysisWen Feng, Zhi Han, Ruixia Zhu, et al.Frontiers in Immunology|April 12, 2024
The intricate dance of non-coding RNAs in myasthenia gravis pathogenesis and treatmentBenqiao Wang, Ying Zhu, Dan Liu, et al.Journal of Molecular Neuroscience : MN|February 13, 2021
Genome-Wide Detection of m6A-Associated Genetic Polymorphisms Associated with Ischemic StrokeRuixia Zhu, Dandan Tian, Yating Zhao, et al.Current Neuropharmacology|January 23, 2026
Efgartigimod in Very-Late-Onset Generalized Myasthenia Gravis: A Real-World Study on Effectiveness and SafetyChi Ma, Jingyi Shen, Ying Zhu, et al.Immunotargets and Therapy|July 20, 2026
Targeting BLyS and APRIL with Telitacicept versus Conventional Immunotherapy in Generalized Myasthenia Gravis: A Comparative StudyYingying Yang, Nan Kang, Ying Zhu, et al.Medicine|March 17, 2021
Association between lncRNA ANRIL genetic variants with the susceptibility to ischemic stroke: From a case-control study to meta-analysisQianwen Wang, Jingjing Zhao, Hongtao Chang, et al.Expert Review of Molecular Diagnostics|March 3, 2022
Role of N6-methyladenosine modification in pathogenesis of ischemic strokeHongtao Chang, Jun Yang, Qianwen Wang, et al.Metabolic Brain Disease|April 5, 2021
Genetic polymorphisms in lncRNAs predict recurrence of ischemic strokeRuixia Zhu, Tongling Xiao, Qianwen Wang, et al.Frontiers in Pharmacology|June 17, 2024
Advancements and prospects of novel biologicals for myasthenia gravis: toward personalized treatment based on autoantibody specificitiesChi Ma, Dan Liu, Benqiao Wang, et al.Annals of Clinical and Translational Neurology|February 24, 2022
Lipid levels and the risk of dementia: A dose-response meta-analysis of prospective cohort studiesYing Zhu, Xu Liu, Ruixia Zhu, et al.Pageof 8